title: Ethanol does not alter the pharmacokinetic profile of the controlled-release formulation of carvedilol.
abstract: The concomitant ingestion of alcohol may alter the release of a drug from a modified-release dosage form, posing a potential risk to patients. In a randomized, open-label, 4-period cross-over study, the pharmacokinetic profiles of R(+) and S(-) carvedilol were compared after a single oral dose of carvedilol controlled-release formulation (administered following a standard meal) was given alone or concomitantly with ethanol. Thirty-nine healthy subjects participated in this study. Following coadministration of carvedilol controlled-release 40 mg with ethanol (approximately 38 g), ethanol ingestion 2 hours before or 2 hours after carvedilol controlled-release administration, area under the curve for the R(+) and S(-) carvedilol enantiomers was similar compared with carvedilol controlled-release given alone. Carvedilol exposure was not affected by the concomitant administration of ethanol and carvedilol controlled-release. Maximum plasma concentrations for the R(+) and S(-) carvedilol enantiomers were similar except when ethanol was ingested 2 hours after carvedilol controlled-release administration, where there was a modest decrease in maximum plasma concentration for R(+) and S(-) carvedilol (16% and 17%, respectively). Carvedilol controlled-release given alone or concomitantly with ethanol ingestion was generally well tolerated, and no serious or severe adverse events were reported. Ethanol did not alter the pharmacokinetic profile of carvedilol controlled-release.
authors.affiliation: GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA.
authors.forename: Linda S
authors.initials: LS
authors.lastname: Henderson
authors.forename: David M
authors.initials: DM
authors.lastname: Tenero
authors.forename: Andrea M
authors.initials: AM
authors.lastname: Campanile
authors.forename: Charlotte A
authors.initials: CA
authors.lastname: Baidoo
authors.forename: Theodore M
authors.initials: TM
authors.lastname: Danoff
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000493:pharmacokinetics*; D002227:Carbazoles / Q000493:pharmacokinetics*; D000077261:Carvedilol; D002492:Central Nervous System Depressants / Q000008:administration & dosage*; D003430:Cross-Sectional Studies; D003692:Delayed-Action Preparations / Q000493:pharmacokinetics; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000493:pharmacokinetics*
chemical_list: D000959:Antihypertensive Agents; D002227:Carbazoles; D002492:Central Nervous System Depressants; D003692:Delayed-Action Preparations; D011412:Propanolamines; D000077261:Carvedilol; D000431:Ethanol